Advanced Enzyme Technologies 将来の成長

Future 基準チェック /46

Advanced Enzyme Technologiesは、26.7%と15.6%でそれぞれ年率26.7%で利益と収益が成長すると予測される一方、EPSはgrowで26.8%年率。

主要情報

26.7%

収益成長率

26.8%

EPS成長率

Chemicals 収益成長	22.9%
収益成長率	15.6%
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	17 May 2024

今後の成長に関する最新情報

Recent updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Jul 19

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Jul 13

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Apr 08

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Sep 23

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Feb 03

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Aug 11

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

May 13

Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

Mar 28

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Mar 13

Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Feb 21

Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 18

I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

Feb 03

What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

Jan 19

What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

Dec 28

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Dec 13

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Nov 28

Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Nov 20

Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

Nov 05

What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Oct 21

業績と収益の成長予測

NSEI:ADVENZYMES - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2026	7,888	2,114	2,105	2,405	1
3/31/2025	7,014	1,797	2,892	3,192	1
9/30/2024	6,194	1,371	904	1,422	N/A
6/30/2024	6,311	1,386	N/A	N/A	N/A
3/31/2024	6,239	1,333	941	1,414	N/A
12/31/2023	6,048	1,371	N/A	N/A	N/A
9/30/2023	5,859	1,248	965	1,327	N/A
6/30/2023	5,668	1,166	N/A	N/A	N/A
3/31/2023	5,406	1,056	1,022	1,404	N/A
12/31/2022	5,337	979	N/A	N/A	N/A
9/30/2022	5,251	960	806	1,164	N/A
6/30/2022	5,135	995	N/A	N/A	N/A
3/31/2022	5,294	1,196	941	1,223	N/A
12/31/2021	5,309	1,268	N/A	N/A	N/A
9/30/2021	5,350	1,424	1,127	1,374	N/A
6/30/2021	5,325	1,500	N/A	N/A	N/A
3/31/2021	5,018	1,459	1,434	1,630	N/A
12/31/2020	4,820	1,459	N/A	N/A	N/A
9/30/2020	4,569	1,364	978	1,472	N/A
6/30/2020	4,481	1,301	N/A	N/A	N/A
3/31/2020	4,440	1,293	904	1,409	N/A
12/31/2019	4,480	1,302	N/A	N/A	N/A
9/30/2019	4,366	1,210	1,147	1,276	N/A
6/30/2019	4,288	1,148	N/A	N/A	N/A
3/31/2019	4,220	1,111	1,162	1,286	N/A
12/31/2018	4,194	1,061	N/A	N/A	N/A
9/30/2018	4,261	1,068	N/A	N/A	N/A
6/30/2018	4,199	1,039	N/A	N/A	N/A
3/31/2018	3,918	901	N/A	1,160	N/A
12/31/2017	3,660	837	N/A	N/A	N/A
9/30/2017	3,213	725	N/A	N/A	N/A
6/30/2017	3,127	793	N/A	N/A	N/A
3/31/2017	3,290	915	N/A	1,074	N/A
12/31/2016	3,260	942	N/A	N/A	N/A
9/30/2016	3,404	998	N/A	N/A	N/A
6/30/2016	3,184	854	N/A	N/A	N/A
3/31/2016	2,938	759	N/A	934	N/A
3/31/2015	2,233	510	N/A	537	N/A
3/31/2014	2,397	201	N/A	433	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ADVENZYMESの予測収益成長率 (年間26.7% ) は貯蓄率 ( 6.7% ) を上回っています。

収益対市場: ADVENZYMESの収益 ( 26.7% ) はIndian市場 ( 17.9% ) よりも速いペースで成長すると予測されています。

高成長収益: ADVENZYMESの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: ADVENZYMESの収益 ( 15.6% ) Indian市場 ( 10.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: ADVENZYMESの収益 ( 15.6% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ADVENZYMESの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Advanced Enzyme Technologies 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Price target decreased to ₹265

Price target increased to ₹380

Recent updates

Investor sentiment deteriorates as stock falls 22%

Second quarter 2025 earnings released: EPS: ₹2.94 (vs ₹3.08 in 2Q 2024)

New minor risk - Share price stability

Advanced Enzyme Technologies Limited to Report Q2, 2025 Results on Nov 09, 2024

Insider recently sold ₹51m worth of stock

Investor sentiment improves as stock rises 17%

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Investor sentiment improves as stock rises 16%

First quarter 2025 earnings released: EPS: ₹3.05 (vs ₹2.58 in 1Q 2024)

Advanced Enzyme Technologies Limited to Report Q1, 2025 Results on Aug 10, 2024

Advanced Enzyme Technologies Approves Final Dividend for the Financial Year Ended March 31, 2024

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Upcoming dividend of ₹1.10 per share

Full year 2024 earnings released: EPS: ₹11.92 (vs ₹9.45 in FY 2023)

Advanced Enzyme Technologies Limited, Annual General Meeting, Jul 25, 2024

Advanced Enzyme Technologies Limited, Annual General Meeting, Jul 25, 2024

Insider recently sold ₹11m worth of stock

Insider recently sold ₹6.9m worth of stock

Insider recently sold ₹6.9m worth of stock

Final dividend of ₹4.00 announced

Full year 2024 earnings released: EPS: ₹11.92 (vs ₹9.45 in FY 2023)

Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2023-2024

Advanced Enzyme Technologies Limited to Report Q4, 2024 Results on May 11, 2024

Advanced Enzyme Technologies Limited (NSEI:ADVENZYMES) acquired additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million

Third quarter 2024 earnings released: EPS: ₹3.74 (vs ₹2.63 in 3Q 2023)

Advanced Enzyme Technologies Limited to Report Q3, 2024 Results on Feb 10, 2024

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

Advanced Enzyme Technologies Limited to Report Q2, 2024 Results on Nov 07, 2023

First quarter 2024 earnings released: EPS: ₹2.58 (vs ₹1.60 in 1Q 2023)

Advanced Enzyme Technologies Declares Final Dividend for the Financial Year Ended March 31, 2023

Advanced Enzyme Technologies Limited to Report Q1, 2024 Results on Aug 12, 2023

Upcoming dividend of ₹1.00 per share at 1.2% yield

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Advanced Enzyme Technologies Limited Proposes Dividend Payable on or After August 16, 2023

Insufficient new directors

Chairman recently bought ₹142m worth of stock

Chairman recently bought ₹2.7m worth of stock

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Advanced Enzyme Technologies Limited Announces Board Changes

Advanced Enzyme Technologies Limited to Report Q4, 2023 Results on May 13, 2023

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Third quarter 2023 earnings released: EPS: ₹2.63 (vs ₹2.46 in 3Q 2022)

Advanced Enzyme Technologies Limited to Report Q3, 2023 Results on Feb 11, 2023

Advanced Enzyme Technologies Limited (BSE:540025) completed the acquisition of additional 4.83% stake in JC Biotech Private Limited.

Price target decreased to ₹265

Advanced Enzyme Technologies Limited to Report Q2, 2023 Results on Nov 11, 2022

Insider recently sold ₹100m worth of stock

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Advanced Enzyme Technologies Limited Announces Appointment of Mr. Nitin Jagannath Deshmukh as an Independent Director of the Company

Upcoming dividend of ₹1.00 per share

Advanced Enzyme Technologies Limited Proposes Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Advanced Enzyme Technologies Limited, Annual General Meeting, Aug 19, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Advanced Enzyme Technologies Limited Recommends Dividend for the Financial Year Ended March 31, 2022

Advanced Enzyme Technologies Limited to Report Q4, 2022 Results on May 20, 2022

Price target increased to ₹380

Third quarter 2022 earnings: EPS misses analyst expectations

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Advanced Enzyme Technologies Limited Announces Demise of Vilas Aurangabadkar, Independent Director

Insider recently sold ₹611k worth of stock

Second quarter 2022 earnings released: EPS ₹2.66 (vs ₹3.33 in 2Q 2021)

Advanced Enzymes Announces Positive Clinical Breakthrough in the Randomized Controlled Trials of Systemic Enzymes and Probiotics to Resolve Long Covid' Fatigue Symptoms

Upcoming dividend of ₹0.90 per share

Advanced Enzyme Technologies Limited (BSE:540025) completed the acquisition of additional 15% minority stake in JC Biotech Private Limited.

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

First quarter 2022 earnings released: EPS ₹3.40 (vs ₹3.07 in 1Q 2021)

Full year 2021 earnings released: EPS ₹13.09 (vs ₹11.58 in FY 2020)

Advanced Enzyme Technologies Limited Recommends Dividend for the Financial Year Ended March 31, 2021

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

Investor sentiment improved over the past week